3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
55
INDUSTRY
10
OTHER_GOV
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
41
Cisplatin
40
Paclitaxel
35
Radiotherapy
32
Docetaxel
19
Pemetrexed
18
Gemcitabine
17
Etoposide
17
Bevacizumab
11
Radiosurgery
10
Magnetic Resonance Spectroscopy
9
Ramucirumab
8
durvalumab
7
Taxes
7
Cetuximab
7
pembrolizumab
6
Specimen Handling
6
Erlotinib Hydrochloride
6
Irinotecan
5
Gene Expression Profiling
5
Filgrastim
5
cediranib
4
Vinorelbine
4
Polymerase Chain Reaction
4
Neoadjuvant Therapy
4
Fluorodeoxyglucose F18
4
Chemotherapy, Adjuvant
4
Amplified Fragment Length Polymorphism Analysis
4
tremelimumab
3
osimertinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Immune Checkpoint Inhibitors
×
Thoracic
×
Clear all
NCT05522660
2026-04-27
USZ-STRIKE
ETOP IBCSG Partners Foundation
Phase 3
Recruiting
180 enrolled